MedTrace Logo

A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents

NCT01691430 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.

Conditions

  • Bacteriuria

Interventions

DIETARY_SUPPLEMENT

2 cranberry capsules

Two cranberry capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC)

DIETARY_SUPPLEMENT

Placebo

Two placebo capsules qd (each capsule containing 36mg proanthocyanidin, total 72mg PAC)

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Manisha Juthani-Mehta, M.D. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01691430 on ClinicalTrials.gov